Senior investor and operating executive focused on growth-stage technology and healthcare businesses, Teresa Douberly brings cross-functional experience in corporate finance, strategic operations and board advisory. Known for sourcing and scaling revenue models, she has worked with PE and VC sponsors on diligence, portfolio value creation and exit planning. Market-facing skills include M&A execution, KPI-driven performance improvement and leadership in commercial transformation.
Senior investor and operating executive focused on growth-stage technology and healthcare businesses, Teresa Douberly brings cross-functional experience in corporate finance, strategic operations and board advisory. Known for sourcing and scaling revenue models, she has worked with PE and VC sponsors on diligence, portfolio value creation and exit planning. Market-facing skills include M&A execution, KPI-driven performance improvement and leadership in commercial transformation.
Focuses on growth-stage technology and healthcare companies, prioritizing revenue-driven business models and repeatable commercial motion. Emphasizes diligence on unit economics, scalable go-to-market KPIs and capital-efficient customer acquisition; deploys growth equity or structured minority capital with three- to seven-year horizons tied to EBITDA or strategic exit milestones. Blends operator-led value creation and board-level governance to derisk commercialization, favoring companies where M&A optionality and margin expansion are clear.
Focuses on growth-stage technology and healthcare companies, prioritizing revenue-driven business models and repeatable commercial motion. Emphasizes diligence on unit economics, scalable go-to-market KPIs and capital-efficient customer acquisition; deploys growth equity or structured minority capital with three- to seven-year horizons tied to EBITDA or strategic exit milestones. Blends operator-led value creation and board-level governance to derisk commercialization, favoring companies where M&A optionality and margin expansion are clear.
| Trades 1306 | Longs Won 951/1306 72% | Profit Factor 13.6 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $352,696.48 |
| Average Win $87,474.86 | Best Trade (Jul 16) $9.32M | Sharpe Ratio -98.74 |
| Average Loss -$17,229.96 | Worst Trade (Jul 10) -$442,235.44 | Z-Score 12.2 (100%) |
| Commissions $0 | Avg. Trade Length 1y 2m 2w 6d | Expectancy $59,013.75 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 15,385 | 13,846 | 12,308 | 10,769 | 9,231 | 7,692 | 6,154 | 4,615 | 3,077 | 1,538 |